NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
Back to search
Official data from USPTO
BIOVENTIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
01/28/2026
Trademark type
Word
Nice classes
1, 5
Filing date
05/21/2024
Registration date
01/27/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
01/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
London, GB
Examiner
LEARNED, GLEN D
Law office
O40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Bioventix PLC
Representatives
Christopher D. Casavale Nelson Mullins Riley & Scarborough LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals preparations for use in industryscience and photographyas well as in agriculturehorticulture and forestry except fungicidesherbicidesinsecticidesparasiticide; antibody reagents used for detection of antigens in cells and tissueother than for medical or veterinary purposes; monoclonal antibody reagentsother than for medical or veterinary purposes; monoclonal antibodies for scientific purposes; Chemical preparationsradio-labelled monoclonal antibody for industrial or scientific use and not for medical or veterinary purposes; Chemical preparationsradio-labelled monoclonal antibody for industrial or scientific use for medical or diagnostic purposes; reagents for scientific and research usereagents for development of monoclonal antibodies other than for medical or veterinary purposes
Class 5
Sanitary preparations for medical purposes; antibodies for medical purposes; antibody fragments for medical purposes; antibody reagents used for detection of antigens in cells and tissuefor medical and diagnostic purposes; antibodies and antibody fragments for medical and veterinary diagnostics; antibodies and antibody fragments for use in the discoverypreclinical and clinical development of medical therapeutic products; biological indicators for use in medical diagnosis of diseasesdeficienciesorgan disease and disfunctioncancerfertility issuesfor medical purposes ; reactants for use in medical diagnosisin the nature of substances or compounds that can facilitate a reaction for use in medical testsfor use in medical diagnosis of diseasesdeficienciesorgan disease and disfunctioncancerfertility issuesfor medical purposes; medical reagents for use in the development of monoclonal antibodies for medical purposes; veterinary reagents for use in the development of monoclonal antibodies for veterinary purposes; diagnostic reagents for medical diagnostics and medical useveterinary diagnostics and veterinary useclinical diagnostics and clinical use and chemical testing
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/09/2025
PUBO
PUBLISHED FOR OPPOSITION
12/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/30/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/30/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/30/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/31/2025
GNFR
FINAL REFUSAL E-MAILED
03/31/2025
CNFR
FINAL REFUSAL WRITTEN
03/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/05/2024
GNRT
NON-FINAL ACTION E-MAILED
12/05/2024
CNRT
NON-FINAL ACTION WRITTEN
12/05/2024
DOCK
ASSIGNED TO EXAMINER
12/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/24/2024
NWAP
NEW APPLICATION ENTERED
05/21/2024
Continuous trademark protection
Get notified about every new filing that threatens BIOVENTIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.